Business Description
Saniona AB
ISIN : SE0005794617
Total Employee Number:
43Compare
Compare
Traded in other countries / regions
SANION.Sweden0RQJ.UK30S.Germany IPO Date
2020-01-15Description
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1984.99 | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | 49.66 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 22.19 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 151.2 | |||||
3-Year Book Growth Rate | 86 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 10.7 | |||||
9-Day RSI | 18.64 | |||||
14-Day RSI | 23.58 | |||||
3-1 Month Momentum % | -17.34 | |||||
6-1 Month Momentum % | -32.83 | |||||
12-1 Month Momentum % | 281.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.55 | |||||
Quick Ratio | 10.55 | |||||
Cash Ratio | 10 | |||||
Days Sales Outstanding | 14.3 | |||||
Days Payable | 1282.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.2 | |||||
Shareholder Yield % | -5.05 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 98.66 | |||||
Operating Margin % | 54.62 | |||||
Net Margin % | 51.14 | |||||
EBITDA Margin % | 57.19 | |||||
FCF Margin % | 42.01 | |||||
OCF Margin % | 59.44 | |||||
ROE % | 43.53 | |||||
ROA % | 38.6 | |||||
ROIC % | 202.55 | |||||
3-Year ROIIC % | 734.55 | |||||
ROC (Joel Greenblatt) % | 396.99 | |||||
ROCE % | 47.3 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.39 | |||||
Forward PE Ratio | 6.42 | |||||
PE Ratio without NRI | 8.39 | |||||
Price-to-Owner-Earnings | 8.09 | |||||
PS Ratio | 4.17 | |||||
PB Ratio | 3 | |||||
Price-to-Tangible-Book | 3.01 | |||||
Price-to-Free-Cash-Flow | 9.95 | |||||
Price-to-Operating-Cash-Flow | 6.94 | |||||
EV-to-EBIT | 5.45 | |||||
EV-to-EBITDA | 5.31 | |||||
EV-to-Revenue | 3.05 | |||||
EV-to-FCF | 7 | |||||
Price-to-GF-Value | 0.48 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Price-to-Graham-Number | 1.06 | |||||
| Price-to-Net-Current-Asset-Value | 3.53 | |||||
| Price-to-Net-Cash | 3.75 | |||||
Earnings Yield (Greenblatt) % | 18.33 | |||||
FCF Yield % | 9.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Saniona AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 429.29 | ||
| EPS (TTM) (kr) | 1.55 | ||
| Beta | 2.0823 | ||
| 3-Year Sharpe Ratio | 0.7 | ||
| 3-Year Sortino Ratio | 3.33 | ||
| Volatility % | 166.74 | ||
| 14-Day RSI | 23.58 | ||
| 14-Day ATR (kr) | 0.044322 | ||
| 20-Day SMA (kr) | 12.75 | ||
| 12-1 Month Momentum % | 281.31 | ||
| 52-Week Range (kr) | 3.63742 - 26.65 | ||
| Shares Outstanding (Mil) | 138.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Saniona AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Saniona AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-26 08:00 | In 146 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 08:00 | In 55 days | ||
| General meeting for 2026 | 2026-05-27 16:30 | 13.55 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-26 08:00 | 13.55 (+0.00%) | ||
| Annual report for 2025 | 2026-04-30 | 14.31 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 08:00 | 22.85 (-1.93%) | ||
| Third quarter earnings results for 2025 | 2025-11-27 08:00 | 15.62 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 08:00 | 11.56 (+0.00%) | ||
| General meeting for 2025 | 2025-05-28 16:30 | 3.64 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-28 08:00 | 3.64 (+0.00%) |
Show
Entries
Saniona AB Frequently Asked Questions
What is Saniona AB(CHIX:SANIOs)'s stock price today?
The current price of CHIX:SANIOs is kr12.75. The 52 week high of CHIX:SANIOs is kr26.65 and 52 week low is kr3.64.
When is next earnings date of Saniona AB(CHIX:SANIOs)?
The next earnings date of Saniona AB(CHIX:SANIOs) is 2026-08-27.
Does Saniona AB(CHIX:SANIOs) pay dividends? If so, how much?
Saniona AB(CHIX:SANIOs) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Saniona AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers